This Week on NeurologyLive — May 24, 2021


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

A new Insights series has launched! The "Use of High-Efficacy Therapies for Treatment of Relapsing Multiple Sclerosis" series features Lawrence Steinman, MD, and Enrique Alvarez, MD, PhD, who offer their perspectives on a number of topics around the use of disease-modifying therapies in MS. They also discuss the role of MRI and the McDonald Criteria in diagnosis and define key differences in the presentation and prevalence of the clinical subtypes, among other topics.

To catch up on the series, click here.

This week, clips of a conversation NeurologyLive staff had with Robert Zivadanov, MD, PhD, professor of neurology; Director, Translational Imaging Center at Clinical Translational Research Center; and director, Buffalo Neuroimaging Analysis Center, will go live! He shared his insight into the novel biomarker he and colleagues have assessed in progressive multiple sclerosis, as well as recapped some of the findings of post hoc analyses of the ORATORIO trial he presented at AAN 2021.

To check out all of our conversations with Zivadanov, click here.

Throughout the week, the NeurologyLive Peers & Perspectives series, "The Patient-Centered Visit & Shared Decision Making in the Management of Migraine," will air additional episodes. The series features Jill Dehlin, RN, a patient advocate and migraineur, Amaal J. Starling, MD, a migraine specialist at Mayo Clinic, who offer their insights into the existing stigmas associated with the disease, strategies to empower patients with migraine, advocacy resources, and the importance of quality of life measures in the patient population, among other topics of discussion.

To catch up on the series, click here.

On Friday, May 28, be sure to check out the MJH Life Sciences Medical World News channel, as a number of new shows featuring your peers and colleagues in medicine will air! This week, NeurologyLive will appear on "Inside the Practice." The episode will feature Aaron Boster, MD, who will offer an inside look at some of the unique features of his private practice and the ways he's adapted to the virtual push brought on by the COVID-19 pandemic.

To check out what's on the Medical World News channel now, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, also goes live on Wednesday, May 26. This week, it features Barry Hendin, MD, of the Multiple Sclerosis Center of Arizona, and Center for Neurology and Spine, to hear about the progress that’s been made in the MS treatment landscape ahead of World MS Day on May 30. As the landscape has continually and rapidly evolved, he shared insight into the importance of getting the community access to information on the latest options available to them.

To check out the prior NeuroVoices conversations, click here.

Throughout the week, the NeurologyLive Peers & Perspectives series, "Dystrophin and Its Role in Effective Treatment of Duchenne Muscular Dystrophy (DMD)," will air new episodes! This series features Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, who discuss all things related to the care of patients with DMD. Thus far, the pair has given a review of the condition overall and the mutations involved with it as well as discussed micro-dystrophin, its place in gene therapy developments, and relevance in the clinical setting in relation to DMD.

To catch up on the series, click here.

In case you missed it on Friday: Episode 37 of the NeurologyLive "Mind Moments" podcast has premiered. This time, the show featured a conversation with Matthew B. Harms, MD, associate professor of neurology, Columbia University, and medical consultant and care center director, Muscular Dystrophy Association, in honor of ALS Awareness Month. Harms discussed the impact that awareness efforts have had on the clinical development in ALS, and offered an update on the current landscape of care.

To subscribe on your favorite podcast player, click here.

As a reminder, the June 2021 print issue of the NeurologyLive is coming up! In the meantime, catch up with the April 2021 issue now on our website. Some of the feature pieces included are "Magnetic Resonance’s Impact on Diagnosis, Prognostication, and Therapeutic Approaches in Neuromuscular Disorders," by Kenneth Bender, PharmD, MA; "A Critical Evaluation of Disease-Modifying Strategies in Parkinson Disease," by Fernando L. Pagan, MD, Charbel Moussa, MBBS, PhD, and Yasar Torres-Yaghi, MD; and "Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation," by Atom Sarkar, MD, PhD, among others.

To view the issue in digital form, click here.

If you missed your chance to register for last week's free webinar broadcast, part of our series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, fear not! You can still join Ahmed Obeidat, MD, PhD; Mitch Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.

To view the enduring version of both the first and second programs, click here.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.